Cost analysis of therapy for patients with multiple sclerosis (MS) in Poland.
Journal Title: Pharmacological Reports - Year 2008, Vol 60, Issue 5
Abstract
Multiple sclerosis (MS) is a neurological disease of the central nervous system in which dissipated demyelination lesions develop. The currently available pharmacotherapy and rehabilitation for this disease aims to preserve the patients' physical abilities and prevent disease progression and nervous system damage. The study evaluated the direct and indirect costs associated with two different treatment regimens for multiple sclerosis diagnosed patients by comparing two groups of 60 subjects (Group A - patients receiving continuous interferon therapy (Betaferon) and steroids during relapses, and Group B - patients receiving steroid-only (Solu-Medrol, Metypred) treatment). The study was conducted over two years (2004-2005). The pharmacotherapy costs for MS patients were: PLN 4,555,360.68 (1,171,043.88euro) total for Group A and PLN 75,922.68 (19,517.40euro) per patient, and PLN 72,582.00 (18,658.61euro) total for Group B and PLN 1,209.70 (310.98euro) per patient. Total direct and indirect costs for Group A and Group B amounted to PLN 5,595,968.58 (1,438,552.33euro) and PLN 1,655,658.30 (425,619.10euro), respectively.
Authors and Affiliations
Arleta Matschay, Elzbieta Nowakowska, Hanka Hertmanowska, Krzysztof Kus, Anna Czubak
Keywords
Related Articles
- EP ID EP134071
- DOI -
- Views 90
- Downloads 0
Pharmacological evaluation of bradykinin effect on human umbilical artery in normal, hypertensive and diabetic pregnancy.
The objective of this investigation was to compare bradykinin (BK) action on isolated intact or denuded human umbilical artery (HUA) in normal pregnancy, pregnancy-induced hypertension (PIH) and gestational diabetes mell...
Statins: a new insight into their mechanisms of action and consequent pleiotropic effects.
In the recent years, 3-hydroxy-3-methylglutaryl coenzyme A(HMG-CoA) reductase inhibitors have emerged as the most important class of lipid-lowering agents. Through inhibition of HMG-CoA reductase, they restrict the rate-...
Characteristics of adrenaline-driven receptor-mediated signals in human microvessel-derived endothelial cells.
Adrenaline (0.001-1,000 muM) strongly stimulated adenosine-3',5'cyclic monophosphate (cAMP) generation in cultured human microvascular-derived endothelial cells (HMEC-1). Isoprenaline mimicked the action of adrenaline, w...
Elimination kinetics of the novel prodrug cinazepam possessing psychotropic activity in mice.
The kinetics of excretion of the novel tranquilizer cinazepam (3-hydroxy-7-bromo-5-(ortho-chlorophenyl)-1,2-dihydro-3H-1,4-benzdiazepin-2-one hemisuccinate (I)) in mice after a single administration and different schemes...
Pharmacological activity of calcimimetic NPS R-568 administered intravenously in rats: dose dependency.
Calcimimetics administered orally cause "pharmacological parathyroidectomy" confirmed by a decrease in parathyroid hormone secretion (PTH) and in plasma Ca(2+) concentration. Parathyroidsare also the source of parathyroi...